miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
The decline of oxygen tension in the tissues below the physiological demand leads to the hypoxic adaptive response. This physiological consequence enables cells to recover from this cellular insult. Understanding the cellular pathways that mediate recovery from hypoxia is therefore critical for developing novel therapeutic approaches for cardiovascular diseases and cancer. The master regulators of oxygen homeostasis that control angiogenesis during hypoxia are hypoxia-inducible factors (HIFs). HIF-1 and HIF-2 function as transcriptional regulators and have both unique and overlapping target genes, whereas the role of HIF-3 is less clear. HIF-1 governs the acute adaptation to hypoxia, whereas HIF-2 and HIF-3 expressions begin during chronic hypoxia in human endothelium. When HIF-1 levels decline, HIF-2 and HIF-3 increase. This switch from HIF-1 to HIF-2 and HIF-3 signaling is required in order to adapt the endothelium to prolonged hypoxia. During prolonged hypoxia, the HIF-1 levels and activity are reduced, despite the lack of oxygen-dependent protein degradation. Although numerous protein factors have been proposed to modulate the HIF pathways, their application for HIF-targeted therapy is rather limited. Recently, the miRNAs that endogenously regulate gene expression via the RNA interference (RNAi) pathway have been shown to play critical roles in the hypoxia response pathways. Furthermore, these classes of RNAs provide therapeutic possibilities to selectively target HIFs and thus modulate the HIF switch. Here, we review the significance of the microRNAs on the relationship between the HIFs under both physiological and pathophysiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Hypoxia (0.8% O2) induces dynamic changes in the protein expression profile of the Hif-1α, Hif-2α and HIF-3α in primary HUVECs (pooled from 10 donors, passage 3). The protein levels of were detected with SDS-PAGE and Western blot and normalized to β Actin levels. Two individual samples (20 µg of total protein per lane) were tested for each time point, and the experiments were repeated twice. The primary antibodies used were: Hif-1α (Abcam ab16066, diluted at 1:2000); Hif-2α (Abcam ab199, diluted at 1:1000), Hif-3α [12] (Sigma AV39936, diluted at 1:1000), beta Actin (Abcam ab1801, diluted at 1:1000)](https://figures.cochat.ai/paper-figures/9269b2d975a44874afd2c03aabf465e0/mirnas-regulate-the-hif-switch-during-hypoxia-a-novel-therapeutic-target-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, HIF-β subunits are constitutively expressed in an oxygen-independent manner; thus, degradation of HIF-α prevents the formation of transcriptionally active HIF heterodimers [48]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [48]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Therefore, it is plausible that increased levels of 2-HG may enable a switch to an entirely HIF-independent mechanism.”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [159]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cai, Q., Wang, Z., Wang, S., Weng, M., Zhou, D., Li, C., Wang, J., Chen, E., & Quan, Z. (2017) · Open Biology · doi:10.1098/rsob.160247 · Cited by 107
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Mature miRNAs recognize their target mRNAs through base-pairing interactions between nucleotides numbers 2 and 8 of the miRNA (the seed region) and the complementary nucleotides in the 3′-untranslated region (3′-UTR) of the mRNAs [87].”
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“The amino-terminal end of both α and β subunits consists of basic helix–loop–helix (bHLH) and PAS (PER–ARNT–SIM) domains that mediate heterodimerization and DNA binding [6].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 4×
“There are three different HIFs, HIF-1, HIF-2 and HIF-3, that are present in human tissues and are tightly regulated through changes in oxygen tension [4].”
BackgroundInfluentialMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · cited 2×
“There are three different HIFs, HIF-1, HIF-2 and HIF-3, that are present in human tissues and are tightly regulated through changes in oxygen tension [4].”
BackgroundHIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 2×
“HIFs in response to the unmet oxygen demand of cells activate a number of signaling pathways that are required for cell survival [3].”
BackgroundHentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558 · cited 14×
“The carboxy-terminal domain of HIF-1α and HIF-2α consists of domains that regulate its stability (the oxygen-dependent degradation domain, ODD) and transcriptional activity (two transactivation domains (TADs), N-TAD and C-TAD [6].”
BackgroundInfluentialMolecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex
Han, J., Lee, Y., Yeom, K.-H., Nam, J.-W., Heo, I., Rhee, J.-K., Sohn, S. Y., Cho, Y., Zhang, B.-T., & Kim, V. N. (2006) · Cell · doi:10.1016/j.cell.2006.03.043 · Cited by 1,551
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts
Geisler, S., & Coller, J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3679 · Cited by 1,463
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
Appelhoff, R. J., Tian, Y.-M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., & Gleadle, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406026200 · Cited by 1,108
A MicroRNA Signature of Hypoxia
Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01395-06 · Cited by 1,055 · cited 1×
“Although hypoxia and ischemia change the expression profiles of many miRNAs [88], a functional role for a limited number of these so-called hypoxamiRs [89] has been demonstrated and number of these that affect HIF expression have been identified [90].”
BackgroundIntegration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007) · PubMed Central · Cited by 894
A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity
Cifuentes, D., Xue, H., Taylor, D. W., Patnode, H., Mishima, Y., Cheloufi, S., Ma, E., Mane, S., Hannon, G. J., Lawson, N. D., et al. (2010) · Science · doi:10.1126/science.1190809 · Cited by 836
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
MicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758 · cited 1×
“Finally, the hypoxic recruitment of the CREBBP and p300 to HIF complexes allows an additional level of modulation of HIF transcriptional activity in response to various environmental stimuli [20], whereas the hypoxia-induced sirtuin 1 (SIRT1) selectively deacetylates HIF-1α during hypoxia and leads to increased HIF-1…”
BackgroundWidespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C., Hörstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 740
Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S. R., Bouxsein, M. L., Faugere, M.-C., Guldberg, R. E., Gerstenfeld, L. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31581 · Cited by 733
Kallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Morpholino antisense oligomers: the case for an RNase H-independent structural type
Summerton, J. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00150-5 · Cited by 664
hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
Camps, C., Buffa, F. M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., Harris, A. L., Gleadle, J. M., & Ragoussis, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1755 · Cited by 662
Yu, A. Y., Shimoda, L. A., Iyer, N. V., Huso, D. L., Sun, X., McWilliams, R., Beaty, T., Sham, J. S. K., Wiener, C. M., Sylvester, J. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5912 · Cited by 656
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
Hua, Z., Lv, Q., Ye, W., Wong, C.-K. A., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., Yang, B. B., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000116 · Cited by 655
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647
Wiesener, M. S., Turley, H., Allen, W. E., Willam, C., Eckardt, K.-U., Talks, K. L., Wood, S. M., Gatter, K. C., Harris, A. L., Pugh, C. W., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2260 · Cited by 635
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
Expanding the MicroRNA Targeting Code: Functional Sites with Centered Pairing
Shin, C., Nam, J.-W., Farh, K. K.-H., Chiang, H. R., Shkumatava, A., & Bartel, D. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.005 · Cited by 611 · cited 1×
“Mature miRNAs are incorporated into the Argonaute-containing silencing complexes called the miRNA ribonucleoprotein complex (miRNP) and down regulate specific target mRNAs via either decreasing the transcript levels or by translational repression [85, 86].”
BackgroundUmezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., & Ohyashiki, J. H. (2014) · Blood · doi:10.1182/blood-2014-05-576116 · Cited by 600 · cited 1×
“An exosomal miR-135b formed during hypoxia in multiple myeloma cells directly suppresses HIF1AN in HUVECs and leads to increased HIF-1 activity and angiogenesis [124].”
BackgroundPassing the baton: the HIF switch
Koh, M. Y., & Powis, G. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.004 · Cited by 589
Mole, D. R., Blancher, C., Copley, R. R., Pollard, P. J., Gleadle, J. M., Ragoussis, J., & Ratcliffe, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901790200 · Cited by 552
Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H.-P., Ferrara, N., & Johnson, R. S. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.026 · Cited by 540
Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430
Choi, W.-Y., Giraldez, A. J., & Schier, A. F. (2007) · Science · doi:10.1126/science.1147535 · Cited by 517
Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg Effect
Yang, F., Zhang, H., Mei, Y., & Wu, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.11.004 · Cited by 510
Scortegagna, M., Ding, K., Oktay, Y., Gaur, A., Thurmond, F., Yan, L.-J., Marck, B. T., Matsumoto, A. M., Shelton, J. M., Richardson, J. A., et al. (2003) · Nature Genetics · doi:10.1038/ng1266 · Cited by 496
Pre-mRNA splicing in the new millennium
Hastings, M. L., & Krainer, A. R. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00212-x · Cited by 485
Liu, Y. V., Baek, J. H., Zhang, H., Diez, R., Cole, R. N., & Semenza, G. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.001 · Cited by 478
Peng, J., Zhang, L., Drysdale, L., & Fong, G.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140087397 · Cited by 460 · cited 2×
“Importantly, HIF-2α knockout mice did not show impaired blood vessels formation by vasculogenesis, but later fusion and assembly, suggesting that HIF-2α activity is critical for the remodeling of the primary vascular network into a mature hierarchy pattern [52].”
BackgroundAcute postnatal ablation of Hif-2 α results in anemia
Gruber, M., Hu, C.-J., Johnson, R. S., Brown, E. J., Keith, B., & Simon, M. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608382104 · Cited by 457
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Yamakuchi, M., Lotterman, C. D., Bao, C., Hruban, R. H., Karim, B., Mendell, J. T., Huso, D., & Lowenstein, C. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911082107 · Cited by 430
Uchida, T., Rossignol, F., Matthay, M. A., Mounier, R., Couette, S., Clottes, E., & Clerici, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400461200 · Cited by 428
Ghosh, G., Subramanian, I. V., Adhikari, N., Zhang, X., Joshi, H. P., Basi, D., Chandrashekhar, Y. S., Hall, J. L., Roy, S., Zeng, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42980 · Cited by 420
Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1
Rolfs, A., Kvietikova, I., Gassmann, M., & Wenger, R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20055 · Cited by 401
Takeda, K., Ho, V. C., Takeda, H., Duan, L.-J., Nagy, A., & Fong, G.-H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00425-06 · Cited by 401
Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V. A., Frei, U., Wiesener, M., & Eckardt, K. (2004) · The FASEB Journal · doi:10.1096/fj.04-1640fje · Cited by 398
Perspectives on Oxygen Sensing
Semenza, G. L. (1999) · Cell · doi:10.1016/s0092-8674(00)81957-1 · Cited by 385 · cited 1×
“Cell survival during hypoxia requires the activation of a number of molecular signaling pathways that stimulate angiogenesis, erythropoietin production and metabolism reprogramming to favor glycolysis, and this biological response is termed the hypoxic adaptive response [1].”
Peng, Y., Yuan, G., Ramakrishnan, D., Sharma, S. D., Bosch‐Marce, M., Kumar, G. K., Semenza, G. L., & Prabhakar, N. R. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114033 · Cited by 366
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
Gnarra, J. R., Ward, J. M., Porter, F. D., Wagner, J. R., Devor, D. E., Grinberg, A., Emmert-Buck, M. R., Westphal, H., Klausner, R. D., & Linehan, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9102 · Cited by 362
MicroRNA therapeutics: Discovering novel targets and developing specific therapy
Bansal, P., Christopher, A., Kaur, R., Kaur, G., Kaur, A., & Gupta, V. (2016) · Perspectives in Clinical Research · doi:10.4103/2229-3485.179431 · Cited by 360
MicroRNA-210: A unique and pleiotropic hypoxamir
Chan, S. Y., & Loscalzo, J. (2010) · Cell Cycle · doi:10.4161/cc.9.6.11006 · Cited by 357
microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age
Noren Hooten, N., Abdelmohsen, K., Gorospe, M., Ejiogu, N., Zonderman, A. B., & Evans, M. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010724 · Cited by 357 · cited 1×
“Indeed, many miRNAs are expressed in tissueand age-specific patterns [91].”
BackgroundHu, C.-J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0419 · Cited by 355
Koh, M. Y., Lemos, R., Liu, X., & Powis, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4142 · Cited by 350
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Wallace, E. M., Rizzi, J. P., Han, G., Wehn, P. M., Cao, Z., Du, X., Cheng, T., Czerwinski, R. M., Dixon, D. D., Goggin, B. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0473 · Cited by 336
Generating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 330
Biology of hypoxia-inducible factor-2α in development and disease
Patel, S. A., & Simon, M. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.17 · Cited by 327
Long noncoding RNAs in kidney and cardiovascular diseases
Lorenzen, J. M., & Thum, T. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.51 · Cited by 322
Iron-regulatory proteins limit hypoxia-inducible factor-2α expression in iron deficiency
Sanchez, M., Galy, B., Muckenthaler, M. U., & Hentze, M. W. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1222 · Cited by 294
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., Simpson, D. A., Leonard, M. O., Tambuwala, M. M., Cummins, E. P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01276-10 · Cited by 289
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
Zhang, Z., Sun, H., Dai, H., Walsh, R., Imakura, M., Schelter, J., Burchard, J., Dai, X., Chang, A. N., Diaz, R. L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9387 · Cited by 283
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
Maxwell, P. H., & Eckardt, K.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.193 · Cited by 283
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Xia, Y., Choi, H.-K., & Lee, K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.033 · Cited by 278
Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation
HUDZIAK, R. M., BAROFSKY, E., BAROFSKY, D. F., WELLER, D. L., HUANG, S.-B., & WELLER, D. D. (1996) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1996.6.267 · Cited by 275
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
Ivan, M., & Kaelin, W. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.002 · Cited by 273
Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz, S., Acker, T., Rauter, M., Plate, K., Sieweke, M., Breier, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211298200 · Cited by 271
Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela-Arispe, L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 255
The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J. J., Visk, D., Haddad, G. G., Poellinger, L., Peet, D. J., Powell, F., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.001 · Cited by 246
Summerton, J. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780487740 · Cited by 238
Chan, Y. C., Khanna, S., Roy, S., & Sen, C. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158790 · Cited by 237
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235
Luo, W., Zhong, J., Chang, R., Hu, H., Pandey, A., & Semenza, G. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068577 · Cited by 232
Dai, Z., Li, M., Wharton, J., Zhu, M. M., & Zhao, Y.-Y. (2016) · Circulation · doi:10.1161/circulationaha.116.021494 · Cited by 232
Zhang, P., Yao, Q., Lu, L., Li, Y., Chen, P.-J., & Duan, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.011 · Cited by 231
Takahashi, K., Yan, I. K., Haga, H., & Patel, T. (2014) · Journal of Cell Science · doi:10.1242/jcs.141069 · Cited by 231
HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin
Morita, M., Ohneda, O., Yamashita, T., Takahashi, S., Suzuki, N., Nakajima, O., Kawauchi, S., Ema, M., Shibahara, S., Udono, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg117 · Cited by 230
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
van den Beucken, T., Koch, E., Chu, K., Rupaimoole, R., Prickaerts, P., Adriaens, M., Voncken, J. W., Harris, A. L., Buffa, F. M., Haider, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6203 · Cited by 229
MicroRNAs Induced During Ischemic Preconditioning
Lee, S.-T., Chu, K., Jung, K.-H., Yoon, H.-J., Jeon, D., Kang, K.-M., Park, K.-H., Bae, E.-K., Kim, M., Lee, S. K., et al. (2010) · Stroke · doi:10.1161/strokeaha.110.579649 · Cited by 202
Warnecke, C., Griethe, W., Weidemann, A., Jürgensen, J. S., Willam, C., Bachmann, S., Ivashchenko, Y., Wagner, I., Frei, U., Wiesener, M., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1062fje · Cited by 200
Hif-1α regulates differentiation of limb bud mesenchyme and joint development
Provot, S., Zinyk, D., Gunes, Y., Kathri, R., Le, Q., Kronenberg, H. M., Johnson, R. S., Longaker, M. T., Giaccia, A. J., & Schipani, E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612023 · Cited by 198
Lei, Z., Li, B., Yang, Z., Fang, H., Zhang, G.-M., Feng, Z.-H., & Huang, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007629 · Cited by 195
Maynard, M. A., Evans, A. J., Hosomi, T., Hara, S., Jewett, M. A. S., & Ohh, M. (2005) · The FASEB Journal · doi:10.1096/fj.05-3788com · Cited by 193
SNPs in microRNA target sites and their potential role in human disease
Moszyńska, A., Gebert, M., Collawn, J. F., & Bartoszewski, R. (2017) · Open Biology · doi:10.1098/rsob.170019 · Cited by 192
Self-citationExosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia
Yang, Y., Li, Y., Chen, X., Cheng, X., Liao, Y., & Yu, X. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1387-2 · Cited by 185
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
Rupaimoole, R., Wu, S. Y., Pradeep, S., Ivan, C., Pecot, C. V., Gharpure, K. M., Nagaraja, A. S., Armaiz-Pena, G. N., McGuire, M., Zand, B., et al. (2014) · Nature Communications · doi:10.1038/ncomms6202 · Cited by 181
Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene Selection
Aprelikova, O. N., Wood, M. J. A., Tackett, S. A., Chandramouli, G. V. R., & Barrett, J. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3345 · Cited by 180
Bhattacharya, R., SenBanerjee, S., Lin, Z., Mir, S., Hamik, A., Wang, P., Mukherjee, P., Mukhopadhyay, D., & Jain, M. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500200200 · Cited by 174
Park, S.-K., Dadak, A. M., Haase, V. H., Fontana, L., Giaccia, A. J., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4959-4971.2003 · Cited by 169
RACK1 vs. HSP90: Competition for HIF-1α Degradation vs. Stabilization
Liu, Y. V., & Semenza, G. L. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3981 · Cited by 162
Bayer, C., & Vaupel, P. W. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0085-4 · Cited by 157
Akhtar, S., Hartmann, P., Karshovska, E., Rinderknecht, F.-A., Subramanian, P., Gremse, F., Grommes, J., Jacobs, M., Kiessling, F., Weber, C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05886 · Cited by 157
Camps, C., Saini, H. K., Mole, D. R., Choudhry, H., Reczko, M., Guerra-Assunção, J., Tian, Y.-M., Buffa, F. M., Harris, A. L., Hatzigeorgiou, A. G., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-28 · Cited by 157
Functional Importance of Dicer Protein in the Adaptive Cellular Response to Hypoxia
Ho, J. J. D., Metcalf, J. L., Yan, M. S., Turgeon, P. J., Wang, J. J., Chalsev, M., Petruzziello-Pellegrini, T. N., Tsui, A. K. Y., He, J. Z., Dhamko, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373365 · Cited by 156
Pasanen, A., Heikkilä, M. M., Rautavuoma, K., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.008 · Cited by 154
HIF-1 versus HIF-2 — Is one more important than the other?
Loboda, A., Jozkowicz, A., & Dulak, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.006 · Cited by 152 · cited 1×
“HIF-1α and HIF-2α have 48% amino acid sequence identity and similar protein structures, and they differ mainly within the N-TAD domain [8].”
BackgroundZhang, H., Pu, J., Qi, T., Qi, M., Yang, C., Li, S., Huang, K., Zheng, L., & Tong, Q. (2014) · Oncogene · doi:10.1038/onc.2012.574 · Cited by 144
Liu, F., Lou, Y.-L., Wu, J., Ruan, Q.-F., Xie, A., Guo, F., Cui, S.-P., Deng, Z.-F., & Wang, Y. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331054 · Cited by 139
Bartoszewska, S., Rochan, K., Piotrowski, A., Kamysz, W., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2015) · The FASEB Journal · doi:10.1096/fj.14-267054 · Cited by 139
Self-citationSeok, J. K., Lee, S. H., Kim, M. J., & Lee, Y.-M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku515 · Cited by 132
Lin, S.-C., Wang, C.-C., Wu, M.-H., Yang, S.-H., Li, Y.-H., & Tsai, S.-J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1450 · Cited by 129
Kai, A. K., Chan, L. K., Lo, R. C., Lee, J. M., Wong, C. C., Wong, J. C., & Ng, I. O. (2016) · Hepatology · doi:10.1002/hep.28577 · Cited by 128
The role of hypoxia-inducible factor-2 in digestive system cancers
Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.565 · Cited by 122 · cited 2×
“HIF-1 complexes are present in all tissues, whereas HIF-2 is limited to specific cell types that include endothelial cells (ECs), glial cells, type II pneumocytes, cardiomyocytes, kidney fibroblasts, interstitial cells and hepatocytes [29].”
BackgroundKojima, I., Tanaka, T., Inagi, R., Kato, H., Yamashita, T., Sakiyama, A., Ohneda, O., Takeda, N., Sata, M., Miyata, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060639 · Cited by 122
Bhatt, K. S., Wei, Q., Pabla, N., Dong, G., Mi, Q., Liang, M., Mei, C., & Dong, Z. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050463 · Cited by 119
Ge, X., Liu, X., Lin, F., Li, P., Liu, K., Geng, R., Dai, C., Lin, Y., Tang, W., Wu, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8228 · Cited by 117
Role of CBP in regulating HIF-1-mediated activation of transcription
Ruas, J. L., Poellinger, L., & Pereira, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01617 · Cited by 114
Yamashita, T., Ohneda, O., Nagano, M., Iemitsu, M., Makino, Y., Tanaka, H., Miyauchi, T., Goto, K., Ohneda, K., Fujii-Kuriyama, Y., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01332-07 · Cited by 114
Kawanami, D., Mahabeleshwar, G. H., Lin, Z., Atkins, G. B., Hamik, A., Haldar, S. M., Maemura, K., LaManna, J. C., & Jain, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025346 · Cited by 104
Lau, K. W., Tian, Y.-M., Raval, R. R., Ratcliffe, P. J., & Pugh, C. W. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603675 · Cited by 104 · cited 1×
“1 3 independent of selective HRE-binding and relied on the non-equivalent C-terminal regions of these factors’ alpha subunits [38].”
BackgroundRavenna, L., Salvatori, L., & Russo, M. A. (2016) · The FEBS Journal · doi:10.1111/febs.13572 · Cited by 97
He, M., Wang, Q.-Y., Yin, Q.-Q., Tang, J., Lu, Y., Zhou, C.-X., Duan, C.-W., Hong, D.-L., Tanaka, T. T., Chen, G.-Q., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.130 · Cited by 94
Characterization of novel antisense HIF-1α transcripts in human cancers
Bertozzi, D., Iurlaro, R., Sordet, O., Marinello, J., Zaffaroni, N., & Capranico, G. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17183 · Cited by 94
A feedback regulatory loop between HIF‐1α and miR‐21 in response to hypoxia in cardiomyocytes
Liu, Y., Nie, H., Zhang, K., Ma, D., Yang, G., Zheng, Z., Liu, K., Yu, B., Zhai, C., & Yang, S. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.067 · Cited by 94
Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways
Rodriguez, J., Pilkington, R., Garcia Munoz, A., Nguyen, L. K., Rauch, N., Kennedy, S., Monsefi, N., Herrero, A., Taylor, C. T., & von Kriegsheim, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.043 · Cited by 94
Nagpal, N., Ahmad, H. M., Chameettachal, S., Sundar, D., Ghosh, S., & Kulshreshtha, R. (2015) · Scientific Reports · doi:10.1038/srep09650 · Cited by 92
Hypoxia-Induced Alternative Splicing in Endothelial Cells
Weigand, J. E., Boeckel, J.-N., Gellert, P., & Dimmeler, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042697 · Cited by 91
Blick, C., Ramachandran, A., McCormick, R., Wigfield, S., Cranston, D., Catto, J., & Harris, A. L. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.203 · Cited by 88
Staton, A. A., & Giraldez, A. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.423 · Cited by 88
Transcriptional repression of human cad gene by hypoxia inducible factor-1
Chen, K., Lai, Y.-Y., Sun, H. S., & Shaw-Jenq, T. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki839 · Cited by 88
Regulation of angiogenesis by hypoxia: the role of microRNA
Madanecki, P., Kapoor, N., Bebok, Z., Ochocka, R., Collawn, J., & Bartoszewski, R. (2013) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-012-0037-0 · Cited by 87
Self-citationHypoxamiR Regulation and Function in Ischemic Cardiovascular Diseases
Greco, S., Gaetano, C., & Martelli, F. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5403 · Cited by 87
Franke, K., Kalucka, J., Mamlouk, S., Singh, R. P., Muschter, A., Weidemann, A., Iyengar, V., Jahn, S., Wieczorek, K., Geiger, K., et al. (2013) · Blood · doi:10.1182/blood-2012-08-449181 · Cited by 85
Janaszak-Jasiecka, A., Bartoszewska, S., Kochan, K., Piotrowski, A., Kalinowski, L., Kamysz, W., Ochocka, R. J., Bartoszewski, R., & Collawn, J. F. (2016) · Scientific Reports · doi:10.1038/srep22775 · Cited by 81
Self-citationmiRNAs: micro-managers of anticancer combination therapies
B, J. R. V. B., Giovannetti, E., Poel, D., Nowak-Sliwinska, P. M., & Griffioen, A. W. (2017) · Angiogenesis · doi:10.1007/s10456-017-9545-x · Cited by 80
Arora, V., Devi, G. R., & Iversen, P. L. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376706 · Cited by 77
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness
Raspaglio, G., Petrillo, M., Martinelli, E., Puma, D. D. L., Mariani, M., Donato, M. D., Filippetti, F., Mozzetti, S., Prislei, S., Zannoni, G. F., et al. (2014) · Gene · doi:10.1016/j.gene.2014.03.037 · Cited by 75
Dynamic mechanisms for pre-miRNA binding and export by Exportin-5
Wang, X., Xu, X. J., Ma, Z., Huo, Y., Xiao, Z., Li, Y., & Wang, Y. (2011) · RNA · doi:10.1261/rna.2732611 · Cited by 72
Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation
Yang, D., Wang, J., Xiao, M., Zhou, T., & Shi, X. (2016) · Scientific Reports · doi:10.1038/srep35316 · Cited by 67
MicroRNA 107 Partly Inhibits Endothelial Progenitor Cells Differentiation via HIF-1β
Meng, S., Cao, J., Wang, L., Zhou, Q., Li, Y., Shen, C., Zhang, X., & Wang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040323 · Cited by 61
miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells
Bartoszewski, R., Serocki, M., Janaszak‐Jasiecka, A., Bartoszewska, S., Kochan-Jamrozy, K., Piotrowski, A., Króliczewski, J., & Collawn, J. F. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.10.001 · Cited by 61
Self-citationChen, T., Zhou, Q., Tang, H., Bozkanat, K. M., Yuan, J. X. ‐., Raj, J. U., & Zhou, G. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004510 · Cited by 59
Kalinowski, L., Janaszak-Jasiecka, A., Siekierzycka, A., Bartoszewska, S., Woźniak, M., Lejnowski, D., Collawn, J. F., & Bartoszewski, R. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0017-x · Cited by 58
Self-citationDai, L., Lou, W., Zhu, J., Zhou, X., & Di, W. J. (2015) · PubMed · Cited by 55
Xue, D., Yang, Y., Liu, Y., Wang, P., Dai, Y., Liu, Q., Chen, L., Shen, J., Ju, H., Li, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12972 · Cited by 54
Nauta, T. D., van den Broek, M., Gibbs, S., van der Pouw-Kraan, T. C. T. M., Oudejans, C. B., van Hinsbergh, V. W. M., & Koolwijk, P. (2017) · Angiogenesis · doi:10.1007/s10456-016-9527-4 · Cited by 51
Bi, D., Du, J., Hu, R., Wang, A., Wu, W., Hu, C.-P., Li, Y., & Li, X. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.043 · Cited by 49
MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma
Lo Dico, A., Costa, V., Martelli, C., Diceglie, C., Rajata, F., Rizzo, A., Mancone, C., Tripodi, M., Ottobrini, L., Alessandro, R., et al. (2016) · Theranostics · doi:10.7150/thno.14700 · Cited by 49
Poitz, D. M., Augstein, A., Gradehand, C., Ende, G., Schmeißer, A., & Strasser, R. H. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.014 · Cited by 48
Wang, X., Ren, H., Zhao, T., Ma, W., Dong, J., Zhang, S., Xin, W., Yang, S., Jia, L., & Hao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7263 · Cited by 48
Wang, X., Li, J., Wu, D., Bu, X., & Qiao, Y. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215600548 · Cited by 46
Li, Z., MENG, D., Li, G., Xu, J., Tian, K., & Li, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4878 · Cited by 46
WU, F., HUANG, W., & WANG, X. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2546 · Cited by 40
Jiang, W. (2015) · Medical Science Monitor · doi:10.12659/msm.893068 · Cited by 37
Wang, F., Zhang, H., Xu, N., Huang, N., Tian, C., Ye, A., Hu, G., He, J., & Zhang, Y. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1195040 · Cited by 33
Qu, H., Zheng, L., Song, H., Jiao, W., Li, D., Fang, E., Wang, X., Mei, H., Pu, J., Huang, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9813 · Cited by 32
Kobayashi, S., Yamashita, T., Ohneda, K., Nagano, M., Kimura, K., Nakai, H., Poellinger, L., & Ohneda, O. (2015) · Genes to Cells · doi:10.1111/gtc.12215 · Cited by 26
Spinello, I., Quaranta, M. T., Paolillo, R., Pelosi, E., Cerio, A., Saulle, E., Coco, F. L., Testa, U., & Labbaye, C. (2015) · Haematologica · doi:10.3324/haematol.2014.120295 · Cited by 26
MicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia
Xie, Y., Li, W., Feng, J., Wu, T., & Li, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5578 · Cited by 26
Han, X., Liu, L., Niu, J., Yang, J., Zhang, Z., & Zhang, Z. (2015) · Medical Science Monitor · doi:10.12659/msm.894803 · Cited by 23
Zhang, L., Zhang, Y., Zhang, X., Zhang, Y., Jiang, Y., Xiao, X., Tan, J. Y., Yuan, W., & Liu, Y. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0853-1 · Cited by 23
Tsuboi, I., Yamashita, T., Nagano, M., Kimura, K., Salazar, G. T., & Ohneda, O. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24899 · Cited by 22
Loboda, A., Stachurska, A., Dorosz, J., Zurawski, M., Wegrzyn, J., Kozakowska, M., Jozkowicz, A., & Dulak, J. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.05.005 · Cited by 22
Nauta, T. D., Duyndam, M. C. A., Weijers, E. M., van Hinsbergh, V. W. M., & Koolwijk, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160700 · Cited by 18
Nauta, T. D., Duyndam, M. C. A., Weijers, E. M., van Hinsbergh, V. W. M., & Koolwijk, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163840 · Cited by 14
Koh, M. Y., & Powis, G. (2006) · Cancer Research · Cited by 3
Research works printed but not linked: 1
- Koh MY, Powis G (2006) SART1/HAF, a protein widely over expressed in human cancer, decreases HIF-1α levels and inhibits tumor growth. Can Res 66(8 Supplement):409
Cited by
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Tirpe, A. A., Gulei, D., Ciortea, S. M., Crivii, C., & Berindan-Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246140 · Cited by 438
Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 216
Bartoszewski, R., Moszyńska, A., Serocki, M., Cabaj, A., Polten, A., Ochocka, R., Dell'Italia, L., Bartoszewska, S., Króliczewski, J., Dąbrowski, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802650rr · Cited by 199
Self-citationMechanisms of Taxane Resistance
Maloney, S., Spring, C., Morejon-Lasso, L., & Prosperi, J. (2020) · Cancers · doi:10.3390/cancers12113323 · Cited by 198
Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability
Janaszak-Jasiecka, A., Siekierzycka, A., Płoska, A., Dobrucki, I. T., & Kalinowski, L. (2021) · Biomolecules · doi:10.3390/biom11070982 · Cited by 186
Self-citation
Metadata
- Authors
- Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R.
- Affiliations
- Gdańsk Medical University (PL)
- University of Alabama at Birmingham (US)
- Corresponding author
- Bartoszewski, Rafał
- Venue
- Angiogenesis
- Published
- 2018-01-27
- Volume
- 21
- Issue
- 2
- Pages
- 183-202
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- PMC
- PMC5878208
- OpenAlex
- W2787814498
- Cited by
- 288
- References
- 174
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 34 · 2023: 51 · 2022: 45 · 2021: 48 · 2020: 35 · 2019: 23 · 2018: 4
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Angiogenesis (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (NIH P30 DK072482, DK072482)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072482)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- microRNA, hypoxia-inducible factor, HIF-1, HIF-2, hypoxia adaptation, oxygen homeostasis, endothelial cells, chronic hypoxia, HIF-targeted therapy, cardiovascular disease, cancer
- MeSH terms
- Animals, Hypoxia, Gene Expression Regulation, Humans, Transcription, Genetic, Signal Transduction, MicroRNAs, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.